Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Deferoxamine: An Emerging Therapy to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Status: Enrolling
Updated:  7/17/2015
mi
from
Boston, MA
Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Deferoxamine: An Emerging Therapy to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Status: Enrolling
Updated: 7/17/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Status: Enrolling
Updated:  7/20/2015
mi
from
Houston, TX
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Status: Enrolling
Updated: 7/20/2015
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Mesa, AZ
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Advanced Cardiac Specialists
mi
from
Mesa, AZ
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Jonesboro, AR
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
St. Bernard's Medical Center
mi
from
Jonesboro, AR
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Jonesboro, AR
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
NEA Baptist Memorial Hospital
mi
from
Jonesboro, AR
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Jacksonville, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Baptist Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Bakersfield, CA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Bakersfield Heart
mi
from
Bakersfield, CA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Bakersfield, CA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Bakersfield Memorial Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
San Diego, CA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Alvarado Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Sacramento, CA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Mercy General Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Torrance, CA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Torrance Memorial Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Denver, CO
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Bridgeport, CT
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
St. Vincent's Medical Center
mi
from
Bridgeport, CT
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Gainesville, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
North Florida Regional Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Melbourne, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Holmes Regional Medical Center
mi
from
Melbourne, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Orlando, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Pensacola, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Baptist Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Pensacola, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Sacred Heart Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
St. Petersburg, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Bayfront Medical Center
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Stuart, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Martin Memorial Medical Center
mi
from
Stuart, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Tampa, FL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
University Community Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Coeur d'Alene, ID
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Kootenai Medical Center
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Berwyn, IL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
MacNeal Hospital
mi
from
Berwyn, IL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Chicago, IL
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Indianapolis, IN
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
The Indiana Heart Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Shreveport, LA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Cardiovascular Research, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Bangor, ME
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Lewiston, ME
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Central Maine Medical Center
mi
from
Lewiston, ME
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Grand Blanc, MI
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Genesys Regional Medical Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Midland, MI
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Mid Michigan Medical Center
mi
from
Midland, MI
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Mt. Pleasant, MI
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
St. Mary's Medical Center
mi
from
Mt. Pleasant, MI
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Petoskey, MI
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Northern Michigan Hospital
mi
from
Petoskey, MI
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Saginaw, MI
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Southfield, MI
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Providence Hospital
mi
from
Southfield, MI
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Minneapolis, MN
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
North Memorial Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
St. Paul, MN
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
United Heart and Vascular Clinic
mi
from
St. Paul, MN
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Tupelo, MS
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
North Mississippi Medical Center
mi
from
Tupelo, MS
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Joplin, MO
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Freeman West Hospital
mi
from
Joplin, MO
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Springfield, MO
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Cox Medical Centers
mi
from
Springfield, MO
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Camden, NJ
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Our Lady of Lourdes Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Albuquerque, NM
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Heart Hospital of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Gastonia, NC
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Gaston Memorial Hospital
mi
from
Gastonia, NC
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Raleigh, NC
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Wake Medical Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Mansfield, OH
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Medical Central Health System- Mid Ohio Heart Clinic
mi
from
Mansfield, OH
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Oklahoma City, OK
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
The University of Oklahoma Health Science Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Philadelphia, PA
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Presbyterian University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Columbia, SC
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Palmetto Richland Memorial Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Columbia, SC
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Myrtle Beach, SC
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Grand Strand Regional Medical Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated:  7/20/2015
mi
from
Sioux Falls, SD
TAXUS Libertē Post Approval Study
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Avera Heart Hospital of South Dakota
mi
from
Sioux Falls, SD
Click here to add this to my saved trials